AquaVita NextGen review

AquaVita publishes a $599 NAD⁺ offer and asks for payment before the provider meeting. The prescribed supply, pharmacy and renewal need confirmation. Its purchase and delivery-refund policies describe different refund methods, so obtain the applicable terms before paying.

AquaVita, Inc. operates the platform, whose about page links it to AquaVita Wellness & Medspa in Lake Forest. Current product pages list compounded NAD⁺ and glutathione. The seller names Steve Groke as Medical Director and CEO; that disclosure does not establish your assigned clinician or independently verify credentials.

The product flow asks for intake and payment before the provider meeting. Listed meeting hours are 7 am–6 pm Pacific Monday–Saturday and 9:30 am–4:30 pm Sunday. The terms limit service to adults 18 and older with state-specific eligibility; a licensed provider must approve prescribing.

The platform describes independent providers, pharmacies and labs without naming the pharmacy assigned to you. Confirm NAD⁺ eligibility in your state, prescribed supply, labs, visit fees and what happens to payment if treatment is declined.

The current NAD⁺ (10) product is $599, and glutathione is listed at $295. The NAD⁺ title does not establish the earlier ten-injection, ten-week supply; obtain the prescribed dose and supply rather than treating $599 as a monthly price. Confirm whether the selected purchase renews and its full debit, fees and taxes.

General subscription terms require cancellation at least two days before renewal processing and exclude partial-period refunds; the first renewal may be charged early. Appointment changes require 24 hours or the prepaid payment may be forfeited.

Purchase terms make sales final and describe any discretionary refund as store credit. The separate delivery policy allows a discretionary replacement or original-payment refund for damaged, missing or incorrect orders reported within 48 hours with supporting details and photos. Approved refunds take up to 15 business days to process. Neither policy establishes a refund for medical denial; confirm which terms govern your order.

Compounded; not FDA-approved. Prescription required only if a licensed provider finds it appropriate. Current product sourcing and the dispensing pharmacy need confirmation. On the evidence, both wellness products need stating plainly. Compounded NAD⁺ delivered by injection has no controlled human outcome trials supporting the energy, recovery or longevity claims the category is sold on; the one human intravenous study was a pharmacokinetic pilot that found infused NAD⁺ clears from plasma quickly. The rigorous NAD⁺ human data sits with the oral precursors NR and NMN, which reliably raise blood NAD⁺: a raised biomarker, not a demonstrated clinical benefit. Glutathione is weaker still: injectable glutathione has essentially no controlled human outcome evidence for the wellness and skin claims attached to it. Individual results vary.